WHO Moves Into Prequalification Of Biosimilars; Two Anticancers First In Line

 
• By Vibha Sharma
  
HER2
WHO Aims to prequalify two anti-cancer biosimilars, including trastuzumab for breast cancer • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics